latest news releases from the newsroom
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals Reports Third Quarter 2008 Financial Results
REDWOOD CITY, Calif., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the third quarter ended September 30, 2008. The net loss for the third quarter of 2008 was $4.6 million compared to $6.6 million for the third quarter of 2007.
B.O.S. Better Online Solutions Ltd.
BOS Scheduled to Release Third Quarter 2008 Financial Results On Thursday, November 20th 2008
RISHON LEZION, Israel, Nov. 6, 2008 (GLOBE NEWSWIRE) -- B.O.S. Better Online Solutions Ltd. ("BOS" or the "Company") (Nasdaq:BOSC) (TASE:BOSC) a leading provider of comprehensive Mobile and RFID solutions for the enterprise and of Supply Chain Solutions, announced today that it will report financial results for the third quarter 2008 and nine month period ended September 30, 2008, before the market opens on Thursday, November 20, 2008.
Kirby McInerney LLP
8th Circuit Denies C.R. Bard, Inc.'s 23(f) Petition in Urological Catheters Antitrust Case -- BCR
ST. LOUIS, Nov. 6, 2008 (GLOBE NEWSWIRE) -- The U.S. Court of Appeals for the 8th Circuit denied C.R. Bard's Inc.'s ("Bard") (NYSE:BCR) 23(f) Petition seeking to overturn class certification yesterday in Southeast Missouri Hospital, et. al v. C. R. Bard Inc., an antitrust action pending against the company. The plaintiffs in the case are a certified class of hospitals who purchased catheters pursuant to Group Purchasing Organizations (GPOs) contracts, the primary means through which sales of urological catheters to hospitals occur, between February 2003 and the present. A trial is scheduled for April 2009 in Cape Girardeau, Missouri.
SunOpta BioProcess Cellulosic Ethanol Joint Venture Receives $1 Million Minnesota NextGen Grant
MINNETONKA, Minn., Nov. 6, 2008 (GLOBE NEWSWIRE) -- SunOpta Inc. (SunOpta or the Company) (Nasdaq:STKL) (TSX:SOY) today announced that Central Minnesota Cellulosic Ethanol Partners (CMCEP) received notification from the Minnesota Department of Agriculture that it has been awarded an approximately $1 million NextGen matching grant for support of the project entitled "Second Phase Feasibility Study and Detailed Engineering for Commercial 10 Million Gallon Per Year Cellulosic Ethanol Plant." CMCEP is a joint venture between Central MN Ethanol Co-op, Bell Independent Power Corporation (BIPC), and SunOpta BioProcess Inc. (SBI), a subsidiary of SunOpta. Each partner is a one-third owner of the previously announced CMCEP joint venture.
Sonn & Erez PLC
Sonn & Erez Investigating Lehman Principal Protected Notes Claims
FORT LAUDERDALE, Fla., Nov. 6, 2008 (GLOBE NEWSWIRE) -- The securities law firm of Sonn & Erez PLC (http://www.sonnerez.com) announces that it is investigating Financial Industry Regulatory Authority ("FINRA") securities arbitration claims to recover investment losses sustained in Lehman Brothers structured products, namely so-called "principal protected notes." Principal protected notes are believed to have been marketed to conservative, risk-averse investors who were seeking to preserve their capital and generate income as well as share in the growth of the general market. Contrary to a Lehman Brothers brochure that essentially represented that principal protected note investors would enjoy both "100 percent principal protection" and "uncapped appreciation potential," Sonn & Erez believes the notes actually subjected investors to far more risk than they were led to believe. Holders of the Lehman principal protected notes will have to wait in line in Lehman's bankruptcy with other unsecured creditors to recover what is left of their money, unless they choose to bring claims against those who sold the notes. Specifically, Sonn & Erez believes that many brokerage firms, including UBS, Merrill Lynch, JP Morgan, Fidelity, and Wachovia, marketed and sold the Lehman Brothers principal protected notes to their own clients. Lehman's structured products included Suns (Stock Upside Note Securities) and Prudents (Prudential Research Universe Diversified Equity Notes). Other brokerage firms also sold their own structured products and principal protected notes, such as Mitts (Merrill's Market Index Target-Term Securities), Sequins (Citigroup's Select Equity Indexed Notes), and Propels (Morgan Stanley's Protected Performance Equity Linked Securities). In total, nearly $70 billion in structured notes were sold to investors last year alone. Sonn & Erez is an AV-Rated law firm that represents investors nationwide in stockbroker misconduct and investment fraud cases. The firm has represented investors against most major Wall Street brokerage firms in claims involving stocks, bonds, options, auction rate securities, mutual funds, hedge funds, and other structured products. If you lost money in a Lehman Brothers structured note or principal protected note or structured products issued by another brokerage firm, please contact Jeffrey Sonn, Esq. or Jeff Erez at 1-866-372-8311 for a free evaluation. You also may visit the firm on the web at www.sonnerez.com.
Hagens Berman, LLP
Hagens Berman Sobol Shapiro Investigating Cadence Design Systems On Behalf of Shareholders
SEATTLE, Nov. 6, 2008 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP ("Hagens Berman") (http://www.hbsslaw.com/cdns) today announced it is investigating Cadence Design Systems, Inc. ("Cadence" or the "Company") (Nasdaq:CDNS) based on claims the company failed to provide accurate and honest reports to the public and Securities and Exchange Commission (SEC) regarding the Company's financial health and business and operations. Hagens Berman is investigating whether the actions by Cadence and the Company's executive officers violates U.S. securities laws.
Express Scripts, Inc.
Express Scripts Warns of Potential Large Data Breach Tied to Threat
ST. LOUIS, Nov. 6, 2008 (GLOBE NEWSWIRE) -- Express Scripts (Nasdaq:ESRX), one of the largest pharmacy benefit management companies in North America, today announced that it has received a letter from an unknown person or persons trying to extort money from the company by threatening to expose millions of the company's patients' records.
MGP Ingredients Inc.
ConAgra Mills, MGP Ingredients Sign Exclusive Flour Supply Agreement
OMAHA, Neb., Nov. 6, 2008 (GLOBE NEWSWIRE) -- ConAgra Mills, a brand of ConAgra Foods, Inc., (NYSE:CAG) and MGP Ingredients, Inc. (Nasdaq:MGPI) announced today the signing of a new, long-term flour supply agreement. Beginning immediately, MGPI will source flour for its value added wheat protein and starch ingredients exclusively from ConAgra Mills.
SIGA Technologies, Inc.
SIGA Technologies to Present At the Rodman and Renshaw Annual Global Investment Conference
NEW YORK, Nov. 6, 2008 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced that the Company's CEO, Dr. Eric A. Rose, will be presenting at the Rodman and Renshaw Annual Global Investment Conference, on Tuesday, November 11, 2008 at 9:30 a.m. ET at The New York Palace Hotel in New York City.